It is a nootropic drug invented in 1996 by a group Functioning for Merck, Sharp and Dohme, that was the 1st compound made which acts to be a subtype-selective inverse agonist in the αfive subtype with the benzodiazepine binding site to the GABAA receptor. Mainly because of the deficiency of https://menachemf208dmu6.blogvivi.com/profile